Publications by authors named "L Dugoff"
Article Synopsis
- - The study aimed to see if treating mild chronic hypertension (CHTN) during pregnancy would lead to fewer unplanned healthcare visits after childbirth.
- - An analysis of 2,293 pregnant patients showed that overall unplanned healthcare utilization rates were similar between the treatment and control groups, though emergency visits were notably lower in the treated group.
- - Factors like higher BMI and cesarean deliveries were found to increase the likelihood of needing unplanned postpartum care, even though treating mild CHTN showed some specific benefits.
Article Synopsis
- The study focuses on early preterm infants who are small for gestational age (SGA) and examines the role of genetic disorders in their high rates of morbidity and mortality.
- Researchers conducted a retrospective analysis of infants born between 2000-2020, comparing the prevalence of genetic disorders in SGA infants (with and without congenital anomalies) to those who were appropriate for gestational age (AGA).
- Findings revealed that genetic disorders were identified in a small percentage of SGA infants, with trisomies 13, 18, and 21 being the most common, highlighting the need for further research on genetic factors contributing to their health outcomes.
Background: The Chronic Hypertension and Pregnancy Study demonstrated that a target blood pressure of <140/90 mm Hg during pregnancy is associated with improved perinatal outcomes. Outside of pregnancy, pharmacologic therapy for patients with diabetes and hypertension is adjusted to a target blood pressure of <130/80 mm Hg. During pregnancy, patients with both diabetes and chronic hypertension may also benefit from tighter control with a target blood pressure <130/80 mm Hg.
View Article and Find Full Text PDFObjective: To compare differences in postpartum blood pressure (BP) control (BP below 140/90 mm Hg) for participants with hypertension randomized to receive antihypertensive treatment compared with no treatment during pregnancy.
Methods: This study was a planned secondary analysis of a multicenter, open-label, randomized controlled trial (The CHAP [Chronic Hypertension and Pregnancy] trial). Pregnant participants with mild chronic hypertension (BP below 160/105 mm Hg) were randomized into two groups: active (antihypertensive treatment) or control (no treatment unless severe hypertension, BP 160/105 mm Hg or higher).